Filing Details
- Accession Number:
- 0001225208-11-013727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-10 12:35:46
- Reporting Period:
- 2011-05-10
- Filing Date:
- 2011-05-10
- Accepted Time:
- 2011-05-10 12:35:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
105770 | West Pharmaceutical Services Inc | WST | Fabricated Rubber Products, Nec (3060) | 231210010 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1387002 | E John Paproski | 101 Gordon Drive Lionville PA 19341 | President-Delivery Systems | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-05-10 | 9,000 | $14.41 | 34,087 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-05-10 | 9,000 | $46.93 | 25,087 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-10 | 9,000 | $14.41 | 9,000 | $14.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2003-03-09 | 2012-03-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,464 | Indirect | By Savings Plan |
Common Stock | 2,449 | Indirect | Non-Qualified Deferred Compensation Plan |
Footnotes
- Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.